We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App





Sansure Presents Advanced Diagnostic Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025
Print article
Image: Sansure is demonstrating its latest diagnostic technologies at Medlab Middle East 2025 (Photo courtesy of Sansure)
Image: Sansure is demonstrating its latest diagnostic technologies at Medlab Middle East 2025 (Photo courtesy of Sansure)

Sansure Biotech (Hunan, China) is presenting its cutting-edge healthcare solutions and providing live demonstrations of its latest diagnostic technologies at Medlab Middle East 2025.

Sansure is demonstrating its range of portable molecular diagnostic systems including the iPonatic III, iPonatic III Pro, and Q-POC. With its cutting-edge technology, iPonatic III ushers in a new “digital and intelligent” era of molecular diagnostics, empowering healthcare professionals and providing rapid and accurate results. The iPonatic III Pro combines the core technical advantages of the previous generations of iPonatic series products, and integrates better fluid controlling, magnetic beads method for nucleic acid extraction and PCR process, to avoid the traditional PCR experimental process time-consuming, complex operation and other drawbacks. The Q-POC PCR diagnostic platform enables rapid, high-quality, and on-demand multiplex PCR testing with results in approximately 30 minutes. Its flexible design allows testing in any location.

Also featured is the SureXler 48 real-time PCR instrument which is revolutionizing PCR diagnostics with its fast thermal system, completing amplification in just 30 minutes. Designed for high throughput and precision, it offers temperature uniformity at ±0.1°C and detects gene expression changes as low as 1.5-fold. Supporting up to 8 detection channels, the utmost efficiency makes it the best helper in non-clinical sample testing, pathogen detection, and genetic screening. From qualitative analysis to high-resolution melting, SureXler 48 has them all covered. Sansure is also highlighting the compact, high-performance Natch 16S nucleic acid extraction system designed for efficient DNA and RNA extraction with a throughput of 1 to 16 samples. Utilizing magnetic bead technology and 10 mixing modes, it offers quick extraction times of 10-60 minutes, making it ideal for fast-paced diagnostics in areas like women’s health, respiratory diseases, and public health.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.